|
TSR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.68107799586915E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.25569999959363E-07 |
| Normal-vs-Stage2 |
1.428080E-02 |
| Normal-vs-Stage3 |
5.804700E-03 |
| Normal-vs-Stage4 |
7.986400E-02 |
| Stage1-vs-Stage2 |
9.521200E-01 |
| Stage1-vs-Stage3 |
4.022200E-01 |
| Stage1-vs-Stage4 |
5.676200E-01 |
| Stage2-vs-Stage3 |
5.334200E-01 |
| Stage2-vs-Stage4 |
5.838400E-01 |
| Stage3-vs-Stage4 |
9.935000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10960027224871E-10 |
| Normal-vs-AfricanAmerican |
3.417200E-04 |
| Normal-vs-Asian |
3.023400E-01 |
| Caucasian-vs-AfricanAmerican |
2.803000E-01 |
| Caucasian-vs-Asian |
8.239800E-01 |
| AfricanAmerican-vs-Asian |
9.050400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.79799996692066E-09 |
| Normal-vs-Female |
1.3075000004914E-07 |
| Male-vs-Female |
2.829700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.445720E-02 |
| Normal-vs-Extreme_Weight |
4.996400E-04 |
| Normal-vs-Obese |
2.22979999997541E-06 |
| Normal-vs-Extreme_Obese |
2.886800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.148600E-01 |
| Normal_Weight-vs-Obese |
1.502840E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.371000E-01 |
| Extreme_Weight-vs-Obese |
4.002300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.069400E-01 |
| Obese-vs-Extreme_Obese |
2.938600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.099300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.29870020188139E-10 |
| Normal-vs-Age(61-80Yrs) |
3.80720000003887E-06 |
| Normal-vs-Age(81-100Yrs) |
6.740200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.361990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.755800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.098300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.045230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.599500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.023600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.17470510885687E-11 |
| Normal-VS-Type2 PRCC |
7.096100E-03 |
| Normal-VS-KIRP CIMP |
2.264400E-02 |
| Normal-VS-Unclassified PRCC |
1.158030E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.029360E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.378820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.242400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.266300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.296800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.662160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.472500E-02 |
| Normal-vs-N1 |
7.019400E-04 |
| Normal-vs-N2 |
2.750600E-01 |
| N0-vs-N1 |
5.079500E-03 |
| N0-vs-N2 |
3.569000E-01 |
| N1-vs-N2 |
7.859700E-02 |
|
|
